Differential responses of proliferating versus quiescent cells to adriamycin

Experimental Cell Research

Volumn 250, Issue 1, 1999, Pages 131-141

  Siu, Wai Yi ^a   Arooz, Talha ^a   Poon, Randy Y C ^a  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

Author keywords

Apoptosis; Cell cycle; Cell death; DNA damage; Quiescence

Indexed keywords

DOXORUBICIN; PROTEIN P21; PROTEIN P53;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE PHASE; CELL DEATH; CELL MEMBRANE; CELL PROLIFERATION; CELL SIZE; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; DNA CONTENT; DNA DAMAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0000507213     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1999.4551     Document Type: Article

References (32)

1. Hartwell L. H., Weinert T. A. Checkpoints: Controls that ensure the order of cell cycle events. Science. 246:1989;629-634.
2. Elledge S. J. Cell cycle checkpoints: Preventing an identity crisis. Science. 274:1996;1664-1671.
3. Poon R. Y. C. Bertino J. R. Encyclopedia of Cancer. 1996;246-255 Academic Press, San Diego.
4. Morgan D. O. Cyclin-dependent kinases: Engines, clocks, and microprocessors. Annu. Rev. Cell Dev. Biol. 13:1997;261-291.
5. 160 by the cyclin-dependent kinase-interacting phosphatase KAP in the absence of cyclin. Science. 270:1995;90-93.
6. Mueller P. R., Coleman T. R., Kumagai A., Dunphy W. G. Myt1 - A membrane-associated inhibitory kinase that phosphorylates CDC2 on both threonine-14 and tyrosine-15. Science. 270:1995;86-90.
7. Morgan D. O. Principles of CDK regulation. Nature. 374:1995;131-134.
8. Harper J. W. Cyclin dependent kinase inhibitors. Cancer Surv. 29:1997;91-107.
9. Hunter T., Poon R. Y. C. Cdc37: A protein kinase chaperone. Trends Cell Biol. 7:1997;157-161.
10. Di Leonardo A., Linke S. P., Clarkin K., Wahl G. M. DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev. 8:1994;2540-2541.
11. Liebermann D. A., Hoffman B., Steinman R. A. Molecular controls of growth arrest and apoptosis: p53-dependent and -independent pathways. Oncogene. 11:1995;199-210.
12. Levin A. J. p53, the cellular gatekeeper for growth and division. Cell. 88:1997;323-331.
13. Poon R. Y. C., Jiang W., Toyoshima H., Hunter T. Cyclin-dependent kinases are inactivated by a combination of p21 and Thr14/Tyr15 phosphorylation after UV-induced DNA damage. J. Biol. Chem. 271:1996;13283-13291.
14. Levedakou E. N., Kaufmann W. K., Alcorta D. A., Galloway D. A., Paules R. S. p21CIP1 is not required for the early G2 checkpoint response to ionizing radiation. Cancer Res. 55:1995;2500-2502.
15. Poon R. Y. C., Chau M. S., Yamashita K., Hunter T. The role of Cdc2 feedback loop control in the DNA damage checkpoint in mammalian cells. Cancer Res. 57:1997;5168-5178.
16. Valeriote F., van Putten L. Proliferation-dependent cytotoxicity of anticancer agents: A review. Cancer Res. 35:1975;2619-2630.
17. Jackson R. C. The problem of the quiescent cancer cell. Adv. Enzyme Regul. 29:1989;27-46.
18. Osheroff N., Corbett A. H., Robinson M. J. Mechanism of action of topoisomerase II-targeted antineoplastic drugs. Adv. Pharmacol. 29:1994;105-126.
19. D'Arpa P., Liu L. F. Topoisomerase-targeting antitumor drugs. Biochim. Biophys. Acta. 989:1989;163-177.
20. Keizer H. G., Pinedo H. M., Schuurhuis G. J., Joenje H. Doxorubicin (adriamycin): A critical review of free radical-dependent mechanisms of cytotoxicity. Pharmacol. Ther. 47:1990;219-231.
21. Miller A. D., Garcia J. V., von Suhr N., Lynch C. M., Wilson C., Eiden M. V. Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus. J. Virol. 65:1991;2220-2224.
22. Gossen M., Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA. 89:1992;5547-5551.
23. Poon R. Y. C., Toyoshima H., Hunter T. Redistribution of the CDK inhibitor p27 between different cyclin · CDK complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or UV irradiation. Mol. Biol. Cell. 6:1995;1197-1213.
24. Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65:1983;55-63.
25. Vistica D. T., Skehan P., Scudiero D., Monks A., Pittman A., Boyd M. R. Tetrazolium-based assays for cellular viability: A critical examination of selected parameters affecting formazan production. Cancer Res. 51:1991;2515-2520.
26. Evans H. M., Schulemann W. The action of vital stains belonging to the benzidine group. Science. 34:1914;443-454.
27. Cook J. A., Mitchell J. B. Viability measurements in mammalian cell systems. Anal. Biochem. 179:1989;1-7.
28. Barranco S. C., Novak J. K. Survival responses of dividing and nondividing mammalian cells after treatment with hydroxyurea, arabinosylcytosine, or adriamycin. Cancer Res. 34:1974;1616-1618.
29. Luk C. K., Keng P. C., Sutherland R. M. Regrowth and radiation sensitivity of quiescent cells isolated from EMT6/Ro-fed plateau monolayers. Cancer Res. 45:1985;1020-1025.
30. Crissman H. A., Darzynkiewicz Z., Tobey R. A., Steinkamp J. A. Normal and perturbed Chinese hamster ovary cells: Correlation of DNA, RNA, and protein content by flow cytometry. J. Cell Biol. 101:1985;141-147.
31. Pitkanen K., Haapajarvi T., Laiho M. U.V.C.-induction of p53 activation and accumulation is dependent on cell cycle and pathways involving protein synthesis and phosphorylation. Oncogene. 69:1998;459-469.
32. Leonardo A. D., Linke S. P., Clarkin K., Wahl G. M. DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev. 8:1994;2540-2551.